Northwestern Mutual Wealth Management’s Dyne Therapeutics DYN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.93K	Buy	+267	New	+$4.96K	﹤0.01%	3317

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northwestern Mutual Wealth Management's DYN Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 267 shares worth $5.93K. The stake represents ﹤0.01% of the portfolio and ranks #3317 among its holdings.

246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

Northwestern Mutual Wealth Management held 267 shares of Dyne Therapeutics worth $5.93K as of Q2 2026.
Dyne Therapeutics was a new Northwestern Mutual Wealth Management position in Q2 2026.
Dyne Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3317 holding.
246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.